Parkside Financial Bank & Trust Cara Therapeutics, Inc. Transaction History

Parkside Financial Bank & Trust

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 13, 2022	SELL	$7.45 - $13.84 $990 - $1,840	-133 Reduced 81.1%	31 $0
Q1 2022 May 13, 2022	BUY	$9.94 - $12.65 $1,630 - $2,074	164 New	164 $2,000
Q4 2021 Feb 14, 2022	SELL	$11.99 - $18.14 $3,297 - $4,988	-275 Closed	0 $0
Q3 2021 Oct 29, 2021	BUY	$11.55 - $16.06 $658 - $915	57 Added 26.15%	275 $4,000
Q2 2021 Aug 06, 2021	BUY	$12.38 - $29.19 $2,698 - $6,363	218 New	218 $3,000

102

21.5M

50K

Ticker CARA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,725,900
Market Cap $14M
Description
Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...

Get notified when there are updates to the investment portfolio of Parkside Financial Bank & Trust, based on Form 13F filings with the SEC.

Stay updated on Parkside Financial Bank & Trust with notifications on news.